Two Companies You’ve Never Heard Of Plan Merger Worth More Than Latvia

Medtronic and Covidien plotting the latest healthcare mega-merger, in a deal reportedly worth $40 billion

Two medical-device makers you’ve probably never heard of are in talks to merge for a price that rivals the size of small economies like Latvia, Jordan and Luxembourg.

The two companies, Medtronic and Covidien—who might as well be Transformers for all most people know—are poised to announce a $40 billion deal on Monday, unnamed sources told the Wall Street Journal.

Medtronic makes cardiovascular and orthopedic devices and is based in Minneapolis, while Covidien, which is based in Ireland, makes staplers, feeding pumps and other devices used in surgery.

The deal would lower Medtronic’s tax rate in the United States by coupling it with the lower-taxed Irish company. The U.S. corporate tax rate is 35%, and Ireland’s is 12.5%.

Huge medical company deals are apparently the mergers de nos jours, with Pfizer most recently launching an abortive takeover bid of the U.K.’s AstraZeneca, a roughly $120 billion deal.

According to the International Monetary Fund figures, Latvia’s total gross domestic product in 2013 was $38.9 billion, while Jordan’s was $40 billion and Luxembourg was $42 billion.


Tap to read full story

Your browser is out of date. Please update your browser at http://update.microsoft.com


Dear TIME Reader,

As a regular visitor to TIME.com, we are sure you enjoy all the great journalism created by our editors and reporters. Great journalism has great value, and it costs money to make it. One of the main ways we cover our costs is through advertising.

The use of software that blocks ads limits our ability to provide you with the journalism you enjoy. Consider turning your Ad Blocker off so that we can continue to provide the world class journalism you have become accustomed to.

The TIME Team